Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement
BIRMINGHAM, Ala., June 23 /PRNewswire/ -- According to the World Health Organization (WHO), age-related macular degeneration
(AMD) ranks third as a cause of visual impairment. It is the primary cause of visual impairment in industrial countries with a blindness prevalence of 8.7 percent. A new ...
New Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement
Eye disease product has the potential to preserve vision for millions
BIRMINGHAM, Ala., April 28 /PRNewswire/ -- As many as 17.8 million people will suffer from age-related macular degeneration
(AMD) by 2050 and 1.57 million will be blind from the disease, according to the U.S. Centers for Di...
Nearly 18 Million Will Have Macular Degeneration by 2050
But newer treatments could reduce related blindness by almost 35%, study suggests,,,,
TUESDAY, April 14 (HealthDay News) -- Although the rate of age-related macular degeneration
is on the increase, newer treatments could help reduce the most serious effects of the disease by about 35 p...
VisiVite.com Files for Patent on Unique Macular Degeneration Supplement
Removal of Vitamin E from High Dose Eye Vitamins Provides Safety for Certain Patients.
Huntington, NY (PRWEB) November 18, 2008 -- VisiVite.com, an industry leader in eye health supplements, announced this week the filing for a United States patent application for an ey...
Long-Term Results of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
- Report shows three-line average visual acuity improvement maintained at two years -
SARATOGA, Calif., Nov. 5 /PRNewswire/ -- VisionCare Ophthalmic
Technologies, Inc., a developer of advanced visual prosthetic devices for
individuals with age-related macular degene...
Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk
Eye disease carries same risk as other circulatory problems, experts say.
THURSDAY, Feb. 28 (HealthDay News) -- People suffering from age-related macular degeneration
(AMD) have twice the risk of dying from heart attack or stroke, Australian researchers report.
The degenerative eye...
Study paves way for development of macular degeneration cures
January 28, 2008 Owings Mills, MD -- A new study of age-related macular degeneration
(AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which ...
Mouse Model of Age-Related Macular Degeneration Developed
Researchers say it will allow for testing of new drugs for vision-robbing disease
MONDAY, Jan. 28 (HealthDay News) -- The first animal model of age-related macular degeneration
(AMD) has been developed by Cleveland Clinic researchers.
This mouse model will help improve knowledge ab...
Neurotech Announces Completion of Enrollment of its Phase II/III Retinitis Pigmentosa and Phase II Dry Age Related Macular Degeneration Clinical Studies
LINCOLN, R.I., Nov. 6 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc.,
a biotechnology company focused on the development of sight-saving
therapeutics for chronic retinal diseases, announced today the completion
of enrollment of three on-going clinical studies. Each study is evaluating
Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
License with University of Pittsburgh Brings Additional Key Gene Locus as a Development Opportunity for Recently-Funded Company
NEW HAVEN, Conn., Oct. 23 /PRNewswire/ -- Optherion, Inc., a company
developing products to treat and diagnose dry and wet Age-related Macular
Model to study age-related macular degeneration could pave way for better treatment
PHILADELPHIA - Researchers at the University of Pennsylvania School of Medicine have created the first animal model of age-related macular degeneration
(AMD) caused by a mutation known to produce disease in people, an important first step in developing treatments. The study appears in the October ...
$37 million financing for company based on macular degeneration research
New Haven, Conn. Optherion, Inc. a company that will use groundbreaking discoveries by scientists at Yale and the University of Iowa to develop products to diagnose and treat Age-related Macular Degeneration
(AMD) and other related chronic diseases has received $37 million in start-up financing...
Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration
Stemedica Cell Technologies, Inc., a leader in the manufacturing and development of clinical grade allogeneic adult stem cell technology, has discovered a significant breakthrough in the use of human stem cells and stem cell factors for the potential treatment of degenerations of the retina and r...
FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration
SARATOGA, Calif., March 30 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration
(AMD), today announced the FDA Ophthalmic Devices Advisory Panel unanimously recommended that the FDA approve...
Gene Linked to 'Dry' Macular Degeneration
Study also uncovers risks associated with treating 'wet' form of the eye disease
WEDNESDAY, Aug. 27 (HealthDay News) -- Scientists from the United States and China have identified the first gene directly associated with the onset of severe "dry" macular degeneration, one of two forms o...
Study Finds Potential Cause of Age-Related Macular Degeneration
Data could lead to new drugs to check vascular proliferation that is hallmark of eye disease
MONDAY, March 17 (HealthDay News) -- Researchers have pinpointed a biological pathway that may block the blood vessel proliferation and leakiness behind most cases of blindness in the United S...
Off-Label Avastin Use for Wet Macular Degeneration
Treatment Could Save Millions Their Sight
PORTLAND, Ore., Feb. 25 /PRNewswire/ -- The Food and Drug
Administration (FDA) has only approved Avastin for cancer of the colon and
lungs. In off-label use, however, Avastin is proving itself as a "miracle
drug" that's currently used by...
Spring is Time for Age-Related Macular Degeneration (AMD) Awareness
Age-related macular degeneration
(AMD) is the leading cause of visual impairment and blindness in Americans older than 50, affecting// more than two million people.
The American Academy of Ophthalmology wants to remind people that although AMD is incurable, there are new treatments that can ...
Hope For Patients With Macular Degeneration From Manmade Protein
A new man made protein has been shown to reduce potentially blinding blood vessel growth in the cornea following an eye injury //or even surgery by over 50 percent, according to researchers.
'We believe eventually we'll be able to use this protein to help patients in many situations where blo...
Results for Wet Age-Related Macular Degeneration Show Significant Vision Improvements
Research conducted by retina surgeons at The Methodist Hospital shows unprecedented improvements in vision in more than one-third of patients treated with Lucentis? for wet// age-related macular degeneration
(AMD), according to findings published today in the New England Journal of Medicine. AMD is...
Molecule responsible for age associated macular degeneration identified
CLEVELAND--A dart-like molecule that sticks to proteins in the eye is the main trigger for the unchecked growth of blood vessels, according to researchers at Case Western Reserve University and the Cleveland Clinic Cole Eye Institute. //Uncontrolled blood vessel growth is one of the main reasons f...
Age-Related Macular Degeneration Linked To Two Genes
New research led by New York's Columbia University suggests that almost three-quarters of the cases of age-related macular degeneration
(AMD) are linked to two genes. AMD happens to be one of the leading causes of blindness in the world.//
"I am not aware of any other complex disorder where nea...
Age-Related Macular Degeneration - Risk Factors
A new study identifies several new risk factors for age-related macular degeneration, a sight-robbing disease mainly seen in older people.
As the population ages, more and more people worldwide are showing signs of age-related macular degeneration, or AMD. About 30 percent of people over 70 are d...
Macular Degeneration treatment with Laser
is a blinding condition, which currently affects 30 per cent of people over the age of 75. Most people affected with this disease suffer from the dry form that has no proven treatment until now. However, a new laser could offer hope to those suffering from the disease. This las...
New Laser Techniques cure degeneration of the eye
Latest Laser techniques are being developed on a daily basis. One of these latest laser techniques is helpful in the treatment of those suffering from a degenerative eye condition. This degenerative condition cause blood vessels to grow underneath the retina and leak fluid, causing scarring and los...
Beta Carotene Pills Do Not Remedy Age-related Macular Degeneration
Chicago- Beta carotene was thought to remedy eyesight problems, an extension of the advice most of us have grown up with- about carrots// being good for eyesight. A novel research has suggested that beta carotene pills may not be of much use in improving age associated macular degeneration. Age rel...
Mutated Gene and Bad Habits can Lead to Age-related Macular Degeneration
Blame it on your genes and yourself too. Scientists, lead by Dr Debra A. Schaumberg from Brigham and Women's Hospital in Boston,// US, have reported that the presence of a gene mutation as well as risk factors like smoking and obesity increase the chance of developing age-related macular degen...
NMNAT Protein Protects Against Nerve Cell Degeneration
A new study has found out that a protein called NMNAT can delay the neuronal degeneration
process if it is present at a high level. The researchers from Baylor College of// Medicine in a report in the Public Library of Science Biology that appears online today said that NMNAT protects against nerve...
Vision restoration with a drug for macular degeneration
A recent research proposes that the drug used to treat wet age-related macular degeneration
(wet AMD) could also aid in improvement of vision in some people. //
Wet AMD is the biggest cause of loss of vision in the UK. Sight can be regained to some extent in people with a specific type of retina...
Genetic Variation Linked to Age-Related Macular Degeneration
The combination of a certain genetic variation, along with inflammatory factors and smoking, significantly increases the risk of the vision disorder age-related macular degeneration, according to a study.//
Age-related macular degeneration
(AMD) is the most important cause of irreversible visu...
Sleep Disorders Are A Precursor To Brain Degeneration
Researchers at the Mayo Clinic have found that people with sleep disorders develop degenerative brain diseases around 11 years after their disorder is diagnosed //. The findings of the study are to be presented June 19 at the Associated Professional Sleep Societies' SLEEP 2006 meeting in Salt Lake ...
Proper Diet Can Counter Macular Degeneration
The macular degeneration
which is directly related to age can be reduced by eating carrots which contain the nutrient beta carotene, and also food items which contain zinc, and vitamins C and E // . This has been revealed by a new Dutch study. This will contribute towards preventing a condition tha...
Effective Treatment Option For Macular Degeneration
The wet form of macular degeneration
represents about 10 percent of the overall disease prevalence. Age-related macular degeneration
is the leading cause of irreversible, severe vision loss in people 50 years of age and older. // Two new studies show a therapy known as pegaptanib (Macugen) is an e...
Laser may stop macular degeneration
All around the United States, researchers at 24 medical centers hope to arbitrate whether a laser can stop the development of macular degeneration
before it progresses. There are two forms of macular degeneration, wet and dry. //The dry form makes upto75 percent of all cases and is characterized by...
Gene treatment for macular degeneration
As researchers learn more and more about the genes that cause a number of medical conditions, opportunities for treatment with gene therapy become increasingly likely. //In an interview with Jonathan Davidorf, M.D., explained exciting new advances in the treatment of some forms of macular degenerat...
Fast screening for macular degeneration
According to a new study, researchers are investigating a new technique for mapping the back of the retina and screening for the onset of blindness. Age-related macular degeneration
(AMD) is the leading cause of blindness in older people. //A team at the University of Utah now report on a technical...
ICBS to focus on pharmaceutical and environmental markets
...hD at the University of Arizona . Glaucoma is a prevalent eye disease is one of the leading causes of blindness in the world, and Age-Related Macular degeneration
(AMD) is the leading cause of blindness, worldwide, for people over 55 years of age. The incidence of AMD in persons aged 55 is 1% and increases to 15...
Looking at language
...so critical by pinpointing when Parkinson's disease patients have difficulty while processing grammatically complex sentences. In Parkinson's disease, degeneration
of subcortical dopamine-secreting neurons leads not only to motor symptoms but often also to cognitive deficits.
Jesse Hochstadt recorded eye movem...
Anti-growth factor drugs raise hope and concern for treatment of children's eye diseases
...halmology. The two anti-VEGF antibodies available so farbevacizumab and ranibizumabhave been rapidly adopted for the treatment of age-related macular degeneration
(AMD), the leading cause of vision loss in older adults. The antibodies work by blocking the development of new blood vessels (angiogenesis).
Developing gene therapy to fight blindness
...arly as spring of 2010.
The same type of vector has been successfully tested in both animals and humans for a similar type of early-onset retinal degeneration
called Leber's congenital amaurosis.